A Guedes1,2, L Galuppo2, D Hood3, S H Hwang4, C Morisseau4, B D Hammock4. 1. Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, USA. 2. Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, USA. 3. The Hoof Diagnostic and Rehabilitation Clinic, Bryan, Texas, USA. 4. Department Entomology and Nematology, and UC Davis Comprehensive Cancer Center, University of California, Davis, USA.
Abstract
BACKGROUND: The roles of soluble epoxide hydrolase and lipid mediators in inflammatory and neuropathic pain could be relevant in laminitis pain management. OBJECTIVES: To determine soluble epoxide hydrolase (sEH) activity in the digital laminae, sEH inhibitor potency in vitro, and efficacy of a sEH inhibitor as an adjunct analgesic therapy in chronic laminitic horses. STUDY DESIGN: In vitro experiments and clinical case series. METHODS: sEH activity was measured in digital laminae from euthanised healthy and laminitic horses (n = 5-6/group). Potency of 7 synthetic sEH inhibitors was determined in vitro using equine liver cytosol. One of them (t-TUCB; 0.1 mg/kg bwt i.v. every 24 h) was selected based on potency and stability, and used as adjunct therapy in 10 horses with severe chronic laminitis (Obel grades 2, one horse; 3-4, nine horses). Daily assessments of forelimb lifts, pain scores, physiologic and laboratory examinations were performed before (baseline) and during t-TUCB treatment. Data are presented as mean ± s.d. and 95% confidence intervals (CI). RESULTS: sEH activity in the digital laminae from laminitic horses (0.9±0.6 nmol/min/mg; 95% CI 0.16-1.55 nmol/min/mg) was significantly greater (P = 0.01) than in healthy horses (0.17±0.09 nmol/min/mg; CI 0.07-0.26 nmol/min/mg). t-TUCB as an adjunct analgesic up to 10 days (4.3±3 days) in laminitic horses was associated with significant reduction in forelimb lifts (36±22%; 95% CI 9-64%) and in pain scores (18±23%; 95% CI 2-35%) compared with baseline (P = 0.04). One horse developed gas colic and another corneal vascularisation in a blind eye during treatment. No other significant changes were observed. MAIN LIMITATIONS: Absence of control group and evaluator blinding in case series. CONCLUSIONS: sEH activity is significantly higher in the digital laminae of actively laminitic compared with healthy horses, and use of a potent inhibitor of equine sEH as adjunct analgesic therapy appears to decrease signs of pathologic pain in laminitic horses.
BACKGROUND: The roles of soluble epoxide hydrolase and lipid mediators in inflammatory and neuropathic pain could be relevant in laminitis pain management. OBJECTIVES: To determine soluble epoxide hydrolase (sEH) activity in the digital laminae, sEH inhibitor potency in vitro, and efficacy of a sEH inhibitor as an adjunct analgesic therapy in chronic laminitic horses. STUDY DESIGN: In vitro experiments and clinical case series. METHODS: sEH activity was measured in digital laminae from euthanised healthy and laminitic horses (n = 5-6/group). Potency of 7 synthetic sEH inhibitors was determined in vitro using equine liver cytosol. One of them (t-TUCB; 0.1 mg/kg bwt i.v. every 24 h) was selected based on potency and stability, and used as adjunct therapy in 10 horses with severe chronic laminitis (Obel grades 2, one horse; 3-4, nine horses). Daily assessments of forelimb lifts, pain scores, physiologic and laboratory examinations were performed before (baseline) and during t-TUCB treatment. Data are presented as mean ± s.d. and 95% confidence intervals (CI). RESULTS: sEH activity in the digital laminae from laminitic horses (0.9±0.6 nmol/min/mg; 95% CI 0.16-1.55 nmol/min/mg) was significantly greater (P = 0.01) than in healthy horses (0.17±0.09 nmol/min/mg; CI 0.07-0.26 nmol/min/mg). t-TUCB as an adjunct analgesic up to 10 days (4.3±3 days) in laminitic horses was associated with significant reduction in forelimb lifts (36±22%; 95% CI 9-64%) and in pain scores (18±23%; 95% CI 2-35%) compared with baseline (P = 0.04). One horse developed gas colic and another corneal vascularisation in a blind eye during treatment. No other significant changes were observed. MAIN LIMITATIONS: Absence of control group and evaluator blinding in case series. CONCLUSIONS: sEH activity is significantly higher in the digital laminae of actively laminitic compared with healthy horses, and use of a potent inhibitor of equine sEH as adjunct analgesic therapy appears to decrease signs of pathologic pain in laminitic horses.
Authors: Dawn Chen; Randall Whitcomb; Euan MacIntyre; Vinh Tran; Zung N Do; James Sabry; Dinesh V Patel; Sampath K Anandan; Richard Gless; Heather K Webb Journal: J Clin Pharmacol Date: 2011-03-21 Impact factor: 3.126
Authors: Amol M Patwardhan; Armen N Akopian; Nikita B Ruparel; Anibal Diogenes; Susan T Weintraub; Charis Uhlson; Robert C Murphy; Kenneth M Hargreaves Journal: J Clin Invest Date: 2010-04-26 Impact factor: 14.808
Authors: Sumanta Kumar Goswami; Debin Wan; Jun Yang; Carlos A Trindade da Silva; Christophe Morisseau; Sean D Kodani; Guang-Yu Yang; Bora Inceoglu; Bruce D Hammock Journal: J Pharmacol Exp Ther Date: 2016-03-17 Impact factor: 4.030
Authors: Christophe Morisseau; John W Newman; Hsing-Ju Tsai; Preston A Baecker; Bruce D Hammock Journal: Bioorg Med Chem Lett Date: 2006-10-15 Impact factor: 2.823
Authors: Christophe Morisseau; Bora Inceoglu; Kara Schmelzer; Hsing-Ju Tsai; Steven L Jinks; Christine M Hegedus; Bruce D Hammock Journal: J Lipid Res Date: 2010-07-27 Impact factor: 5.922
Authors: Guodong Zhang; Dipak Panigrahy; Lisa M Mahakian; Jun Yang; Jun-Yan Liu; Kin Sing Stephen Lee; Hiromi I Wettersten; Arzu Ulu; Xiaowen Hu; Sarah Tam; Sung Hee Hwang; Elizabeth S Ingham; Mark W Kieran; Robert H Weiss; Katherine W Ferrara; Bruce D Hammock Journal: Proc Natl Acad Sci U S A Date: 2013-04-03 Impact factor: 11.205
Authors: A G P Guedes; F Aristizabal; A Sole; A Adedeji; R Brosnan; H Knych; J Yang; S-H Hwang; C Morisseau; B D Hammock Journal: J Vet Pharmacol Ther Date: 2017-10-25 Impact factor: 1.786
Authors: Naoki Matsumoto; Nalin Singh; Kin Sing Lee; Bogdan Barnych; Christophe Morisseau; Bruce D Hammock Journal: Prostaglandins Other Lipid Mediat Date: 2022-06-30 Impact factor: 3.813
Authors: Bruce D Hammock; Cindy B McReynolds; Karen Wagner; Alan Buckpitt; Irene Cortes-Puch; Glenn Croston; Kin Sing Stephen Lee; Jun Yang; William K Schmidt; Sung Hee Hwang Journal: J Med Chem Date: 2021-02-07 Impact factor: 7.446
Authors: Diyala S Shihadih; Todd R Harris; Sean D Kodani; Sung-Hee Hwang; Kin Sing Stephen Lee; Vengai Mavangira; Briana Hamamoto; Alonso Guedes; Bruce D Hammock; Christophe Morisseau Journal: Front Vet Sci Date: 2020-08-26